|
Effect of Ketamine on Intraoperative Motor Evoked Potentials
RECRUITINGPhase 3Sponsored by University of California, San Francisco
Actively Recruiting
PhasePhase 3
SponsorUniversity of California, San Francisco
Started2023-12-01
Est. completion2026-12-01
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06140927
Summary
The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered increasing doses of ketamine with motor-evoked potentials being measured at each dose, to assess any impacts.
Eligibility
Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria: * Adult patients (\>18 years of age) undergoing posterior spinal fusions. Exclusion Criteria: * Sensitivity or allergy to ketamine. * Schizophrenia or other psychotic conditions * Uncontrolled hypertension with systolic blood pressure greater than 180 mmHg * Myocardial Infarction * Large vascular aneurysms * Patients on ketamine as outpatient therapy.
Conditions4
CancerSpinal StenosisSpine FusionSpine Tumor
Interventions1
Locations1 site
University of California, San Francisco
Find trials near these locations
Related trials
- ACT_for Alcohol Use Disorder and Depression — Centre hospitalier de l'Université de Montréal (CHUM)
- Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest — University of Milano Bicocca
- ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant Depression — University of Saskatchewan
- Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients — Assistance Publique - Hôpitaux de Paris
- Pharmacologic Treatment Augmentation in Chronic Depression — University Hospital Tuebingen
- Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer — Cedars-Sinai Medical Center
- Ketamine for Veterans With Parkinson's Disease — VA Office of Research and Development
- Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2) — Stanford University
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorUniversity of California, San Francisco
Started2023-12-01
Est. completion2026-12-01
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06140927